Business Description
QuiaPEG Pharmaceuticals Holding AB
ISIN : SE0020678159
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.13 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.59 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 90.5 | |||||
3-Year EPS without NRI Growth Rate | 90.2 | |||||
3-Year FCF Growth Rate | 87.6 | |||||
3-Year Book Growth Rate | 48.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.68 | |||||
9-Day RSI | 39.04 | |||||
14-Day RSI | 40.25 | |||||
6-1 Month Momentum % | -32.65 | |||||
12-1 Month Momentum % | -78.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.55 | |||||
Quick Ratio | 0.55 | |||||
Cash Ratio | 0.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -305.2 | |||||
Shareholder Yield % | -18.39 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year ROIIC % | 26.56 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A | |||||
PE Ratio without NRI | N/A | |||||
PB Ratio | 1.03 | |||||
EV-to-EBIT | -2.31 | |||||
EV-to-EBITDA | -3.09 | |||||
EV-to-FCF | -0.95 | |||||
Earnings Yield (Greenblatt) % | -43.08 | |||||
FCF Yield % | -97.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
QuiaPEG Pharmaceuticals Holding AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | 0 | ||
Beta | 4.67 | ||
Volatility % | 161.6 | ||
14-Day RSI | 40.25 | ||
14-Day ATR (€) | 0.000527 | ||
20-Day SMA (€) | 0.00254 | ||
12-1 Month Momentum % | -78.57 | ||
52-Week Range (€) | 0.0001 - 0.0165 | ||
Shares Outstanding (Mil) | 1,489.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
QuiaPEG Pharmaceuticals Holding AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
QuiaPEG Pharmaceuticals Holding AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
QuiaPEG Pharmaceuticals Holding AB Frequently Asked Questions
What is QuiaPEG Pharmaceuticals Holding AB(FRA:99B0)'s stock price today?
When is next earnings date of QuiaPEG Pharmaceuticals Holding AB(FRA:99B0)?
Does QuiaPEG Pharmaceuticals Holding AB(FRA:99B0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |